Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Study of NSCLC, melanoma outcomes points to surrogacy between real-world endpoints and clinical trial endpoints - The Cancer Letter
Basics of survival statistics for oncologists Mehta A, Sharma A - J Curr Oncol
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials | Journal for ImmunoTherapy of Cancer
The Arts, Sciences and Medicine: Progression Free Survival (PFS)
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
CDISC SDTM and ADaM for survival data - ppt download
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
JCM | Free Full-Text | Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Disease Free Survival - an overview | ScienceDirect Topics
![PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30f4b9adffa198bf79a177643e74ec64b4107203/3-Table1-1.png "PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar")
PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
Progression-free survival. Progression-free survival was defined as the... | Download Scientific Diagram
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials | Radiology: Imaging Cancer
Disease Free Survival - an overview | ScienceDirect Topics
Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
Extrapolation from Progression Free Survival to Overall Survival in Oncology | PPT
